All In Biotech

Drug Trial Radar · NCT07242352

Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- eBC

Dynamic Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Genomically and/or Clinically High-risk ER+/HER2- Early Breast Cancer (ADAPTela)

Last checked: Nov 19, 2026Latest source record: Aug 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,520 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,520

Planned (sponsor's estimate)

Start

Apr 29, 2026

Primary completion

Sep 30, 2033

Study completion Sep 30, 2033

Sponsor

Lead sponsor
Women's Cancer Study Group GmbHAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Berlin-Chemie Menarini
First posted
Nov 21, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In this clinical trial, the Sponsor plans to investigate whether patients with HR+/HER2- eBC identified during routine clinical assessments and treatments as having intermediate to high-risk (based on Oncotype DX® or similar tests and on response assessment to 2-6 weeks of preoperative ET) achieve a survival benefit from an initial 5-years use of elacestrant (with or without a CDK 4/6 inhibitor) followed by SoC ET for further 0-2.5 years in comparison to at least 5 up to 7.5 years SoC ET therapy (+/- CDK4/6 inhibitor). Based on several studies in the metastatic setting, it is reasonable to assume that the adjuvant use of elacestrant with or without CDK 4/6 inhibitors will prevent or delay the activation of mechanisms conferring resistance to ET (e.g., ESR1 mutations).

Conditions

  • Breast Cancer
  • HR+/HER2- Breast Cancer

Interventions

  • ElacestrantDrug

    Elacestrant, a tetrahydronaphthalene compound, is a potent, selective, and orally active oestrogen receptor-α (ERα) antagonist and degrader.

  • Standard-of-care endocrine treatmentDrug

    SoC ET comprises all endocrine treatments authorized for the condition under review. The choice is made upon investigator´s discretion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 5-year invasive disease-free survival (iDFS)Time frame: iDFS 5 years

Locations

33 sites in 1 country. Site status is shown where the registry gives one.

  • Staedtisches Klinikum Lueneburg gGmbH Brustkrebszentrum Lueneburg

    Lüneburg, Germany · Recruiting

  • Universitaetsklinikum Mannheim GmbH Frauenklinik

    Mannheim, Baden-Wurttemberg, Germany · Recruiting

  • Universitaetsklinikum Tuebingen AöR Frauenklinik

    Tübingen, Baden-Wurttemberg, Germany · Recruiting

  • Klinikum Esslingen GmbH Klinik für Frauenheilkunde und Geburtshilfe

    Esslingen am Neckar, Baden-Wüttemberg, Germany · Recruiting

  • Praxis Fuer Interdisziplinaere Onkologie And Haematologie GbR

    Freiburg im Breisgau, Baden-Wüttemberg, Germany · Recruiting

  • Klinikum St Marien Amberg Klinik für Frauenheilkunde und Geburtshilfe

    Amberg, Bavaria, Germany · Recruiting

  • Haematologie-Onkologie im Zentrum MVZ GmbH

    Augsburg, Bavaria, Germany · Not yet recruiting

  • Klinikum der Universitaet Muenchen AöR Frauenheilkunde und Geburtshilfe

    München, Bavaria, Germany · Not yet recruiting

  • Rotkreuzklinikum Muenchen gGmbH Interdisziplinäres Brustzentrum

    München, Bavaria, Germany · Recruiting

  • Haematologisch Onkologische Schwerpunktpraxis

    Würzburg, Bavaria, Germany · Recruiting

  • Medical University Of Lausitz Carl Thiem Frauenklinik

    Cottbus, Brandenburg, Germany · Recruiting

  • Mammazentrum Hamburg MVZ GbR

    Hamburg, Free and Hanseatic City of Hamburg, Germany · Not yet recruiting

  • Hämatologische Onkologische Praxis im Medicum

    Bremen, Free Hanseatic City of Bremen, Germany · Recruiting

  • Gesundheitszentrum Wetterau gGmbH Gynäkologische Ambulanz

    Bad Nauheim, Hesse, Germany · Recruiting

  • Centrum für Hämatologie und Onkologie Bethanien

    Frankfurt am Main, Hesse, Germany · Recruiting

  • Elisabeth Krankenhaus GmbH Brustzentrum

    Kassel, Hesse, Germany · Recruiting

  • Medizinische Hochschule Hannover Klinik für Frauenheilkunde und Geburtshilfe Brustzentrum

    Hanover, Lower Saxony, Germany · Recruiting

  • Gemeinschaftspraxis Frauenärzte am Bahnhofsplatz

    Hildesheim, Niedersachen, Germany · Recruiting

  • Klinik Dr. Hancken GmbH

    Stade, Niedersachen, Germany · Recruiting

  • Johanniter GmbH Onkologisches Zentrum

    Bonn, North Rhine-Westphalia, Germany · Recruiting

  • Marienhospital Bottrop gGmbH Klinik für Gynäkologie und Geburtshilfe

    Bottrop, North Rhine-Westphalia, Germany · Recruiting

  • Klinikum Dortmund gGmbH Frauenklinik Dortmund

    Dortmund, North Rhine-Westphalia, Germany · Recruiting

  • Universitaetsklinikum Duesseldorf AöR Klinik für Frauenheilkunde und Geburtshilfe

    Düsseldorf, North Rhine-Westphalia, Germany · Recruiting

  • St.-Antonius-Hospital gGmbH Klinik für Hämatologie und Onkologie

    Eschweiler, North Rhine-Westphalia, Germany · Recruiting

  • St. Barbara-Klinik Hamm GmbH Brustzentrum

    Hamm, North Rhine-Westphalia, Germany · Recruiting

  • Brustzentrum Niederrhein, Johanniter Bethesda Krankenhaus

    Mönchengladbach, North Rhine-Westphalia, Germany · Recruiting

  • Stiftung Mathias-Spital Rheine Brustzentrum

    Rheine, North Rhine-Westphalia, Germany · Recruiting

  • MKS St. Paulus GmbH Märkisches Brustzentrum

    Schwerte, North Rhine-Westphalia, Germany · Recruiting

  • Praxisnetz Hämatologie / internistische Onkologie

    Troisdorf, North Rhine-Westphalia, Germany · Recruiting

  • Marien-Hospital Witten Brustzentrum

    Witten, North Rhine-Westphalia, Germany · Recruiting

  • Helios Universitaetsklinikum Wuppertal Landesfrauenklinik - Brustzentrum

    Wuppertal, North Rhine-Westphalia, Germany · Not yet recruiting

  • Klinikum Mutterhaus der Borromaeerinnen gGmbH

    Trier, Rhineland-Palatinate, Germany · Recruiting

  • HELIOS Klinikum Berlin-Buch GmbH Klinik für Gynäkologie und Geburtshilfe

    Berlin, State of Berlin, Germany · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.